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Patient data

• Patients undergoing esophagectomy often receive enteral
nutrition through jejunostomy tubes (J-tubes)

N=10523

• J-tubes are source of complications, can lead to readmission
• In this study, we will examine the association between jtubes and readmission rates in a national database
• Hypothesis: J-tube placement in esophagectomy leads to
higher readmission rates

Objectives
• Evaluate the readmission rates and mortality associated with
j-tubes post-esophagectomy nationally.

Methods
• Patients with esophagectomy from 2010-2015 were included
in the study from the Nationwide Readmission Database
• Complications were defined using IDC-9 codes
• J-tube comp 536.42, esophagectomy 42.4, V44.4
• Cancer of esophagus code = (150.9)
• Patient data kept in State Inpatient Databases (27 states)
• Normalized variables using codes for all variables
• Weighted averages were used to normalize samples
• Cox regression models used to control confounders

Readmission rates between esophagectomy
patients with and without J-tubes

Male

30.0%

8734 (83%)

Esophagectomy without J-tube
(EWOJ)

2840 (27%)

Esophagectomy with J-tube (EWJ)

7683 (73%)

Esophagectomy with J-tube
previously placed

25.4%

25.0%

24.5%

20.0%

15.0%

5727 (55%)

Table 1: Patient data and breakdown into esophagectomy without J-tubes
(EWOJ), esophagectomy with J-tubes (EWJ), and esophagectomy with J-tube
previously placed before esophagectomy admission.

• Between 2010-2015, patient weighted scores showed 10,523
patients with esophagectomy and included in this study.
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• No significant differences in demographic data (age, sex,
etc.), admission characteristics, or payer model

Figure 2: Readmission rates in esophagectomy patients with and without
jejunostomy tubes. Data are expressed in percents

• Only significant difference was that EWJ group
received more chemotherapy (14.8% vs. 24.1%)
• Index admission mortality significantly lower in EWJ

Conclusion

Hospital events in esophagectomy patients with
and without J-tubes
60.0%

• J-tubes placed in setting of esophagectomy does not increase
risk of 30-day or 180-day readmission

57.1%

• J-tubes may improve same-hospital mortality at time of
index admission and during readmission

50.0%

• May improve mortality at time of surgery for patients
undergoing esophagectomy
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Figure 1: Esophagectomy Procedure. From National Cancer Institute
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/esophagectomy
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